150 related articles for article (PubMed ID: 37020144)
21. The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma.
Haerle SK; Soyka MB; Fischer DR; Murer K; Strobel K; Huber GF; Holzmann D
Eur Arch Otorhinolaryngol; 2012 Jan; 269(1):127-33. PubMed ID: 21713453
[TBL] [Abstract][Full Text] [Related]
22. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
Bikhchandani J; Wood J; Richards AT; Smith RB
Head Neck; 2014 Sep; 36(9):1313-6. PubMed ID: 23956077
[TBL] [Abstract][Full Text] [Related]
23. [The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Fülöp M; Kásler M; Remenár E; Lengyel Z; Borbély K
Magy Onkol; 2012 May; 56(2):84-92. PubMed ID: 22629545
[TBL] [Abstract][Full Text] [Related]
24. FDG PET for mucosal malignant melanoma of the head and neck.
Goerres GW; Stoeckli SJ; von Schulthess GK; Steinert HC
Laryngoscope; 2002 Feb; 112(2):381-5. PubMed ID: 11889401
[TBL] [Abstract][Full Text] [Related]
25. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
26. Demographics and treatment trends in sinonasal mucosal melanoma.
Gal TJ; Silver N; Huang B
Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859
[TBL] [Abstract][Full Text] [Related]
27. Perineural spread of malignant melanoma of the head and neck: clinical and imaging features.
Chang PC; Fischbein NJ; McCalmont TH; Kashani-Sabet M; Zettersten EM; Liu AY; Weissman JL
AJNR Am J Neuroradiol; 2004 Jan; 25(1):5-11. PubMed ID: 14729519
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
29. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
30. Correlation between PET/CT and CT in the staging prior to the treatment of head and neck squamous cell carcinoma.
García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; McGee-Laso A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
Braz J Otorhinolaryngol; 2021; 87(1):11-18. PubMed ID: 31337597
[TBL] [Abstract][Full Text] [Related]
31. Comparison of PET-CT, CT and MRI scan in initial staging and management of head and neck cancers.
Ahmad S; Mair M; Haris PA; Haider A; Baker A; Conboy P; Walter H; Raj L; Wright S; Vaidhyanath R; Thiagarajan S
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2651-2656. PubMed ID: 34546395
[TBL] [Abstract][Full Text] [Related]
32. Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck.
Alvarado GC; Papadopoulos NE; Hwu WJ; Bedikian AY; Homsi J; Myers JN; Bronstein Y; Bassett RL; Hwu P; Kim KB
Melanoma Res; 2011 Apr; 21(2):127-30. PubMed ID: 21169870
[TBL] [Abstract][Full Text] [Related]
33. Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck.
O'Neill JP; Moynagh M; Kavanagh E; O'Dwyer T
J Laryngol Otol; 2010 Dec; 124(12):1274-7. PubMed ID: 20537210
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease.
Ohshima S; Ueki Y; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Okabe R; Matsuyama H; Togashi T; Takatsuka S; Takenouchi T; Horii A
Front Surg; 2022; 9():1032626. PubMed ID: 37082097
[TBL] [Abstract][Full Text] [Related]
35. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Dresel S; Grammerstorff J; Schwenzer K; Brinkbäumer K; Schmid R; Pfluger T; Hahn K
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):995-1003. PubMed ID: 12739070
[TBL] [Abstract][Full Text] [Related]
36. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
37. Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.
Samstein RM; Carvajal RD; Postow MA; Callahan MK; Shoushtari AN; Patel SG; Lee NY; Barker CA
Head Neck; 2016 Sep; 38(9):1310-7. PubMed ID: 27043023
[TBL] [Abstract][Full Text] [Related]
38. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
39. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators.
Kerr EH; Hameed O; Lewis JS; Bartolucci AA; Wang D; Said-Al-Naief N
Int J Surg Pathol; 2012 Feb; 20(1):37-46. PubMed ID: 21862490
[TBL] [Abstract][Full Text] [Related]
40. Staging primary head and neck cancers with (18)F-FDG PET/CT: is intravenous contrast administration really necessary?
Yoshida K; Suzuki A; Nagashima T; Lee J; Horiuchi C; Tsukuda M; Inoue T
Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1417-24. PubMed ID: 19352652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
